219 related articles for article (PubMed ID: 32475585)
1. Targeted delivery of honokiol by zein/hyaluronic acid core-shell nanoparticles to suppress breast cancer growth and metastasis.
Zhang Q; Wang J; Liu D; Zhu W; Guan S; Fan L; Cai D
Carbohydr Polym; 2020 Jul; 240():116325. PubMed ID: 32475585
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
[TBL] [Abstract][Full Text] [Related]
3. Tumor-targeted delivery of honokiol via polysialic acid modified zein nanoparticles prevents breast cancer progression and metastasis.
Zhang Q; Li D; Guan S; Liu D; Wang J; Xing G; Yue L; Cai D
Int J Biol Macromol; 2022 Apr; 203():280-291. PubMed ID: 35093442
[TBL] [Abstract][Full Text] [Related]
4. Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation.
Wang WD; Shang Y; Li Y; Chen SZ
Acta Pharmacol Sin; 2019 Sep; 40(9):1219-1227. PubMed ID: 31235819
[TBL] [Abstract][Full Text] [Related]
5. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
Godugu C; Doddapaneni R; Singh M
Colloids Surf B Biointerfaces; 2017 May; 153():208-219. PubMed ID: 28249200
[TBL] [Abstract][Full Text] [Related]
6. A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies.
Zhou C; Guo C; Li W; Zhao J; Yang Q; Tan T; Wan Z; Dong J; Song X; Gong T
Drug Dev Ind Pharm; 2018 Dec; 44(12):2005-2012. PubMed ID: 30058387
[TBL] [Abstract][Full Text] [Related]
7. Surface modification of pH-sensitive honokiol nanoparticles based on dopamine coating for targeted therapy of breast cancer.
Yu R; Zou Y; Liu B; Guo Y; Wang X; Han M
Colloids Surf B Biointerfaces; 2019 May; 177():1-10. PubMed ID: 30690424
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic Acid-Modified Micelles Encapsulating Gem-C
Liu X; Li W; Chen T; Yang Q; Huang T; Fu Y; Gong T; Zhang Z
Mol Pharm; 2018 Mar; 15(3):1203-1214. PubMed ID: 29397747
[TBL] [Abstract][Full Text] [Related]
9. Responsive functionalized MoSe
Liu Y; Wei C; Lin A; Pan J; Chen X; Zhu X; Gong Y; Yuan G; Chen L; Liu J; Luo Z
Colloids Surf B Biointerfaces; 2020 May; 189():110820. PubMed ID: 32045843
[TBL] [Abstract][Full Text] [Related]
10. CD44 targeting biocompatible and biodegradable hyaluronic acid cross-linked zein nanogels for curcumin delivery to cancer cells: In vitro and in vivo evaluation.
Seok HY; Sanoj Rejinold N; Lekshmi KM; Cherukula K; Park IK; Kim YC
J Control Release; 2018 Jun; 280():20-30. PubMed ID: 29723613
[TBL] [Abstract][Full Text] [Related]
11. Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway.
Pan J; Lee Y; Zhang Q; Xiong D; Wan TC; Wang Y; You M
Cancer Prev Res (Phila); 2017 Feb; 10(2):133-141. PubMed ID: 27849557
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
Wang F; Li L; Liu B; Chen Z; Li C
Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
[TBL] [Abstract][Full Text] [Related]
14. Tuning mPEG-PLA/vitamin E-TPGS-based mixed micelles for combined celecoxib/honokiol therapy for breast cancer.
Sun J; Li J; Liu Q; Jiang M; Yang M; Zhan S; Qiu T; He K; Zhang X
Eur J Pharm Sci; 2020 Apr; 146():105277. PubMed ID: 32105783
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels.
Ju RJ; Cheng L; Qiu X; Liu S; Song XL; Peng XM; Wang T; Li CQ; Li XT
J Drug Target; 2018 Nov; 26(9):793-805. PubMed ID: 29334266
[TBL] [Abstract][Full Text] [Related]
16. Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment.
Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Arch Pharm Res; 2017 Dec; 40(12):1420-1432. PubMed ID: 29027133
[TBL] [Abstract][Full Text] [Related]
17. Quercetagetin-Loaded Composite Nanoparticles Based on Zein and Hyaluronic Acid: Formation, Characterization, and Physicochemical Stability.
Chen S; Sun C; Wang Y; Han Y; Dai L; Abliz A; Gao Y
J Agric Food Chem; 2018 Jul; 66(28):7441-7450. PubMed ID: 29897751
[TBL] [Abstract][Full Text] [Related]
18. Honokiol regulates ovarian cancer cell malignant behavior through YAP/TAZ pathway modulation.
Liu F; Zhang Y; Xia X; Han J; Cao L
J Obstet Gynaecol Res; 2024 Jun; 50(6):1010-1019. PubMed ID: 38576101
[TBL] [Abstract][Full Text] [Related]
19. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
[TBL] [Abstract][Full Text] [Related]
20. Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer.
Chen SH; Liu TI; Chuang CL; Chen HH; Chiang WH; Chiu HC
J Mater Chem B; 2020 May; 8(17):3789-3800. PubMed ID: 32150202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
